Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07232043 · ClinicalTrials.gov registry record · NA
ACTIVATE: AI-driven Clinical-trial Trial-Information and Viability Assessment Tool for EHRs
A NA study, sponsored by Dana-Farber Cancer Institute.
- Not yet
- Registry status
- NA
- Development phase
- 70,000
- Enrollment target
NCT07232043 is a NA study that has not yet begun recruiting, run by Dana-Farber Cancer Institute. The registered enrollment target is 70,000 participants.
The verdict
NCT07232043, a NA study, has not yet begun recruiting, sponsored by Dana-Farber Cancer Institute.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 70,000 participants
- Enrollment target
Study Summary
This study aims to develop and evaluate ACTIVATE, an AI-driven tool for clinical trial information and viability assessment using electronic health records (EHRs). The project will leverage retrospective and prospective EHR data to build and validate algorithms that identify potentially eligible participants for clinical trials and facilitate trial matching.
Interventions
- OTHER MatchMiner-AI Artificial Intelligence Tool
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70,000 participants |
| Start Date | 2026-06 |
| Est. Completion | 2030-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07232043
The ClinicalTrials.gov registry entry for NCT07232043 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 70,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MatchMiner-AI Artificial Intelligence Tool is the first listed.
NCT07232043 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07232043 about?
NCT07232043 is a clinical study titled "ACTIVATE: AI-driven Clinical-trial Trial-Information and Viability Assessment Tool for EHRs". This study aims to develop and evaluate ACTIVATE, an AI-driven tool for clinical trial information and viability assessment using electronic health records (EHRs). The project will leverage retrospective and prospective EHR data to build and validate algorithms that identify potentially eligible par...
What is the current status of trial NCT07232043?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 70,000 participants. The study started on 2026-06. Estimated completion is 2030-06-30.
What interventions are being tested in trial NCT07232043?
The interventions under investigation include: MatchMiner-AI Artificial Intelligence Tool (OTHER).
Who is sponsoring clinical trial NCT07232043?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.